Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

Consolidated Statements of Changes in Stockholders' Equity (USD $) In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2011	$ 19,132us-gaap_StockholdersEquity	$ 19	$ 75,687	$ (56,574)
Balance (in shares) at Dec. 31, 2011		18,604,245
Issuance of Common Stock for cash	28,750	5	28,745	0
Issuance of Common Stock for cash (in shares)		5,750,000
Costs related to issuance of Common Stock	(2,305)	0	(2,305)	0
Exercise of warrants	0	0	0	0
Exercise of warrants (in shares)		21,504
Issuance of Common Stock under ESPP	87	0	87	0
Issuance of Common Stock under ESPP (in shares)		21,644
Issuance of Common Stock for At the Market Offering	19	0	19	0
Issuance of Common Stock for At the Market Offering (in shares)		3,361
Common Stock issuance costs	(1)	0	(1)	0
Stock-based compensation expense	3,961	0	3,961	0
Net loss	(27,610)us-gaap_NetIncomeLoss	0	0	(27,610)
Balance at Dec. 31, 2012	22,033us-gaap_StockholdersEquity	24	106,193	(84,184)
Balance (in shares) at Dec. 31, 2012		24,400,754
Exercise of warrants	1	1	0	0
Exercise of warrants (in shares)		157,355
Exercise of stock options	970	1	969	0
Exercise of stock options (in shares)		550,157
Issuance of Common Stock under ESPP	92	0	92	0
Issuance of Common Stock under ESPP (in shares)		27,570
Issuance of Common Stock for At the Market Offering	91,337	10	91,327	0
Issuance of Common Stock for At the Market Offering (in shares)	10,558,422	10,558,422
Common Stock issuance costs	(1,899)	0	(1,899)	0
Issuance of Restricted Stock	0	4	(4)	0
Issuance of Restricted Stock (in shares)		3,958,692
Stock-based compensation expense	5,902	0	5,902	0
Net loss	(37,158)us-gaap_NetIncomeLoss	0	0	(37,158)
Balance at Dec. 31, 2013	81,278us-gaap_StockholdersEquity	40	202,580	(121,342)
Balance (in shares) at Dec. 31, 2013		39,652,950
Exercise of stock options	596	0	596	0
Exercise of stock options (in shares)	323,412	323,412
Issuance of Common Stock related to subscription	3,502	2	3,500	0
Issuance of Common Stock related to subscription (in shares)		2,175,000
Issuance of Common Stock under ESPP	19	0	19	0
Issuance of Common Stock under ESPP (in shares)		13,980
Common Stock issuance costs	(32)		(32)	0
Issuance of Restricted Stock	0	4	(4)	0
Issuance of Restricted Stock (in shares)		4,328,692
Stock-based compensation expense	5,546	0	5,546	0
Net loss	(20,386)us-gaap_NetIncomeLoss	0	0	(20,386)
Balance at Dec. 31, 2014	$ 70,523us-gaap_StockholdersEquity	$ 46	$ 212,205	$ (141,728)
Balance (in shares) at Dec. 31, 2014		46,494,034